Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» Elevation Oncology
Elevation Oncology
BioSpace Layoff Tracker 2023: Grifols, Frequency, Eliem and More Cut Staff
BioSpace Layoff Tracker 2023: Grifols, Frequency, Eliem and More Cut Staff
BioSpace
layoffs
Grifols
Frequency Therapeutics
Eliem Therapeutics
Aligos Therapeutics
Thermo Fisher Scientific
Magenta Therapeutics
Eisai
Amgen
Y-mAbs Therapeutics
Century Therapeutics
Elevation Oncology
Calithera Biosciences
Editas Medicine
Verily
Abzena
Flag link:
Elevation Oncology dips its toes into ADCs, adding second drug to its bag.
Elevation Oncology dips its toes into ADCs, adding second drug to its bag.
Endpoints
Elevation Oncology
gastric cancer
pancreatic cancer
antibody-drug conjugate
Flag link:
With sickle cell disease study in sight, Graphite Bio draws up a $238M IPO
With sickle cell disease study in sight, Graphite Bio draws up a $238M IPO
MedCity News
Graphite Bio
IPOs
sickle cell disease
Elevation Oncology
Monte Rosa
Flag link:
Elevation files for $100M IPO to fund tumor-agnostic candidate
Elevation files for $100M IPO to fund tumor-agnostic candidate
Fierce Biotech
Elevation Oncology
IPOs
Merrimack Pharmaceuticals
solid tumors
Flag link:
Elevation Oncology launches with $32.5 million Series A, gives new life to former Merrimack program
Elevation Oncology launches with $32.5 million Series A, gives new life to former Merrimack program
Endpoints
Elevation Oncology
Merrimack
seribantumab
non-small cell lung cancer
Flag link:
